The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved a first-of-its-kind cholesterol pill from Merck designed to drive cholesterol levels lower than statins.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Food and Drug Administration has approved a new cholesterol-lowering pill developed by Merck. This treatment is described as a first-of-its-kind medication aimed at slashing cholesterol levels.
Coverage from Reuters, Bloomberg, and The New York Times emphasizes the FDA's approval of the drug. Scientific American highlights that the pill drives cholesterol levels significantly further down than statins, while the Wall Street Journal notes the drug marks the start of a new wave of treatment.
Future developments depend on the rollout of this powerful new medication and its integration into cholesterol treatment protocols.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Which company developed the new cholesterol pill?
The pill was developed by Merck.
How does the new pill compare to statins?
According to Scientific American, the pill drives cholesterol levels far below those achieved by statins.
What is the significance of this approval?
The Wall Street Journal reports that this first-of-its-kind pill ushers in a new wave of treatment.
Coverage (8)
- Merck beats AstraZeneca to first approval for first PCSK9 pill Endpoints News · 3h ago
- FDA approves new kind of cholesterol pill NBC News · 3h ago
- FDA approves Merck’s oral PCSK9 drug, a first STAT · 3h ago
- Merck's cholesterol pill gets US FDA approval Reuters · 3h ago
- U.S. approves pill for cholesterol that drives levels down far below statins Scientific American · 3h ago
- Merck Wins FDA Approval for a Powerful New Cholesterol Pill Bloomberg.com · 3h ago
- Merck’s First-of-Its-Kind Cholesterol Pill Approved, Ushering in New Wave of Treatment WSJ · 3h ago
- The F.D.A. Approves a New Pill to Slash Cholesterol Levels The New York Times · 3h ago
Topics
Related trends
US FDA sued for allowing unauthorized vaping products
Public health organizations are suing the FDA to block policies that allow the sale of unauthorized flavored vaping products.
Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley
Eli Lilly is reportedly nearing a deal to acquire psychedelic drugmaker AtaiBeckley, triggering a sharp surge in the company's stock price.
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
Celcuity shares plummeted by double digits despite the FDA approval of its first breast cancer drug, Revtorpyk.
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
Biogen faces a mixed market reception as new trial data for its tau-targeting Alzheimer's drug shows both promise and significant unanswered questions.
All eyes on data on Biogen’s tau therapy
Biogen's experimental anti-tau therapy, diranersen, shows promise in slowing cognitive decline for early Alzheimer's patients.
FDA releases 14 drug rejection letters after 3-month pause
The FDA has resumed the release of Complete Response Letters (CRLs) after a three-month disclosure freeze, issuing 14 new drug rejection notices.